Munich - Delayed Quote EUR
Halozyme Therapeutics Inc (RV7.MU)
48.19
-0.83
(-1.69%)
As of 5:27:02 PM GMT+2. Market Open.
Loading Chart for RV7.MU
- Previous Close
49.02 - Open
48.81 - Bid 48.57 x --
- Ask 48.68 x --
- Day's Range
48.19 - 48.81 - 52 Week Range
40.03 - 61.69 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: RV7.MU
View MorePerformance Overview: RV7.MU
Trailing total returns as of 6/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
RV7.MU
6.31%
S&P 500 (^GSPC)
0.76%
1-Year Return
RV7.MU
21.26%
S&P 500 (^GSPC)
12.29%
3-Year Return
RV7.MU
13.63%
S&P 500 (^GSPC)
41.89%
5-Year Return
RV7.MU
123.10%
S&P 500 (^GSPC)
92.36%
Compare To: RV7.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RV7.MU
View MoreValuation Measures
As of 5/30/2025
Market Cap
6.07B
Enterprise Value
6.74B
Trailing P/E
14.83
Forward P/E
11.74
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.63
Price/Book (mrq)
14.25
Enterprise Value/Revenue
7.07
Enterprise Value/EBITDA
10.87
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--